MENU
Advertisement
With commentary from Michael P. Thompson, PhD
Reprints
View Supplement
COAPT 5-Year Data Demonstrate Benefits of Mitral TEER, Reveal Need to Address Underlying LV Dysfunction
With commentary from Gregg Stone, MD
left-arrow Created with Sketch. Previous Article
Renal Denervation: Where We Stand After the FDA Panels
With Ajay J. Kirtane, MD, SM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; and Taisei Kobayashi, MD
Next Article right-arrow Created with Sketch.
Modern Clinical Trials Spotlight
Insights on current trial designs, inclusivity, and next steps.
View Issue
Advances in Wiring and Balloon Technology for Complex PCI
With Raghav Gattani, MD, and Lindsey Cilia, MD, FACC, FSCAI
For Suspected Coronary Calcium Nodules, What Is Your Step-by-Step PCI Strategy?
With Shrilla Banerjee, MD, FRCP, FESC; Jimmy L. Kerrigan, MD, FSCAI, FACC; and Aditya S. Bharadwaj, MD, FACC, FSCAI
New PCI Directions
By Louis Verreault-Julien, MD
High-Risk Atherosclerotic Plaque: Defining Features and Assessment on Imaging
By Priyadarshini Dixit, MD; Sierra Fleming, MD; and Olga Toleva, MD, MPH
Severe Calcifications in Chronic Total Occlusions
By Jiho Han, MD, MS, and Margaret McEntegart, MD, PhD